Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome
A lumbar sympathetic ganglion block (LSB) is a therapeutic method for complex regional pain syndrome (CRPS) affecting the lower limbs. Recently, LSB with botulinum toxin type A and B was introduced as a novel method to achieve longer duration of analgesia. In this study, we compared the botulinum to...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-04-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6651/10/4/164 |
| _version_ | 1818000633328828416 |
|---|---|
| author | Yongki Lee Chul Joong Lee Eunjoo Choi Pyung Bok Lee Ho-Jin Lee Francis Sahngun Nahm |
| author_facet | Yongki Lee Chul Joong Lee Eunjoo Choi Pyung Bok Lee Ho-Jin Lee Francis Sahngun Nahm |
| author_sort | Yongki Lee |
| collection | DOAJ |
| description | A lumbar sympathetic ganglion block (LSB) is a therapeutic method for complex regional pain syndrome (CRPS) affecting the lower limbs. Recently, LSB with botulinum toxin type A and B was introduced as a novel method to achieve longer duration of analgesia. In this study, we compared the botulinum toxin type A (BTA) with botulinum toxin type B (BTB) in performing LSB on patients with CRPS. LSB was performed with either BTA or BTB on patients with CRPS in their lower extremities. The length of time taken for patients to return to the pre-LSB pain score and the adverse effect of LSB with BTA/BTB were investigated. The median length of time taken for the patients to return to the pre-LSB pain score was 15 days for the BTA group and 69 days for the BTB group (P = 0.002). Scores on a visual analogue scale decreased in the patients of both groups, and no significant adverse effects were experienced. In conclusion, the administration of either BTA or BTB for LSB is a safe method to prolong the sympathetic blocking effect in patients with CRPS. BTB is more effective than BTA to prolong the sympathetic blocking effect in CRPS patients. |
| first_indexed | 2024-04-14T03:24:53Z |
| format | Article |
| id | doaj.art-e6afc55623de4b3d922903c179cdf464 |
| institution | Directory Open Access Journal |
| issn | 2072-6651 |
| language | English |
| last_indexed | 2024-04-14T03:24:53Z |
| publishDate | 2018-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj.art-e6afc55623de4b3d922903c179cdf4642022-12-22T02:15:13ZengMDPI AGToxins2072-66512018-04-0110416410.3390/toxins10040164toxins10040164Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain SyndromeYongki Lee0Chul Joong Lee1Eunjoo Choi2Pyung Bok Lee3Ho-Jin Lee4Francis Sahngun Nahm5Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaZeropain Clinic, Seoul 02830, KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaA lumbar sympathetic ganglion block (LSB) is a therapeutic method for complex regional pain syndrome (CRPS) affecting the lower limbs. Recently, LSB with botulinum toxin type A and B was introduced as a novel method to achieve longer duration of analgesia. In this study, we compared the botulinum toxin type A (BTA) with botulinum toxin type B (BTB) in performing LSB on patients with CRPS. LSB was performed with either BTA or BTB on patients with CRPS in their lower extremities. The length of time taken for patients to return to the pre-LSB pain score and the adverse effect of LSB with BTA/BTB were investigated. The median length of time taken for the patients to return to the pre-LSB pain score was 15 days for the BTA group and 69 days for the BTB group (P = 0.002). Scores on a visual analogue scale decreased in the patients of both groups, and no significant adverse effects were experienced. In conclusion, the administration of either BTA or BTB for LSB is a safe method to prolong the sympathetic blocking effect in patients with CRPS. BTB is more effective than BTA to prolong the sympathetic blocking effect in CRPS patients.http://www.mdpi.com/2072-6651/10/4/164botulinum toxincomplex regional pain syndromelumbar sympathetic ganglion blockpain |
| spellingShingle | Yongki Lee Chul Joong Lee Eunjoo Choi Pyung Bok Lee Ho-Jin Lee Francis Sahngun Nahm Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome Toxins botulinum toxin complex regional pain syndrome lumbar sympathetic ganglion block pain |
| title | Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome |
| title_full | Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome |
| title_fullStr | Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome |
| title_full_unstemmed | Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome |
| title_short | Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome |
| title_sort | lumbar sympathetic block with botulinum toxin type a and type b for the complex regional pain syndrome |
| topic | botulinum toxin complex regional pain syndrome lumbar sympathetic ganglion block pain |
| url | http://www.mdpi.com/2072-6651/10/4/164 |
| work_keys_str_mv | AT yongkilee lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome AT chuljoonglee lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome AT eunjoochoi lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome AT pyungboklee lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome AT hojinlee lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome AT francissahngunnahm lumbarsympatheticblockwithbotulinumtoxintypeaandtypebforthecomplexregionalpainsyndrome |